EMBR LABS APPOINTS CHIEF MEDICAL OFFICER FOLLOWING MAJOR INTELLECTUAL PROPERTY WINS
16 Nov 2023
Executive Change
BOSTON, Nov. 16, 2023 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading wearable that utilizes temperature for wellness applications, today announced the formal appointment of Dr. Maria Sophocles as Embr Labs' Chief Medical Officer. Dr. Sophocles is a board-certified Ob/Gyn and a Nationally Certified Menopause Practitioner with 28 years of clinical experience. She founded Women's Healthcare of Princeton, a progressive gynecology practice which draws patients from all over the U.S.
Continue Reading
We know that every step forward translates to a meaningful difference in people's lives.
Post this
Preview
Source: PRNewswire
Embr Wave
"I am thrilled to join the Embr Labs team and support their mission to improve lives through the use of temperature regulation. Hot flashes negatively affect women at home and at work. The Embr device gives women agency over their symptoms with on-demand relief for hot flashes. It fills a niche in menopause care that no prescription or OTC product currently does. Embr wave is a treatment modality for women who can't or won't use medications or who want an option to reduce break through hot flashes," stated Dr. Sophocles. "Menopause care needs more than information, it needs action, and the Embr Wave is a device which immediately addresses symptoms — it's not a data tracker, it's a hot flash stopper."
"As we attracted customers utilizing the Embr Wave to manage the symptoms of menopause, it was critical for the company to learn from experts in the field of menopausal medicine. Not only is Dr. Sophocles one of the country's leading menopause practitioners, she's been recommending the Embr Wave to patients since the first generation device and recognizes the value of offering a therapy for patients who are seeking natural solutions" said Elizabeth Gazda, CEO of Embr Labs.
Maria will join forces with Dr. Pamela Peeke who will continue to serve as an advisor and lead Embr's research and support for cancer patients, including Embr Labs' ability to address hot flashes in men who are being treated for prostate cancer.
Dr. Sophocles' appointment follows a strong quarter at Embr Labs as the company extended its global leadership position in wearable thermal technology. Embr Labs was granted five additional utility patents in the US and Japan (US11701250B2, US11759350B2, US11755083B2, JP7333575B2, JP7319691B2). These patents strengthen Embr Labs' competitive advantage and are valuable additions to the existing IP assets that enabled Embr Lab's $35 million intellectual property-based financing this year.
"This group of granted patents reflect the technical leadership and innovative solutions that we have built in our first 10 years at Embr Labs," said Matthew Smith, CTO and Co-founder, "We strive for continuous innovation because we know that every step forward translates to a meaningful difference in people's lives."
The Embr Wave® wristband uses Embr's patented technology to deliver precisely calibrated cooling or warming sensations at the touch of a button for instant, discrete relief and control over hot flashes in menopausal women, improved sleep, and stress management. Clinical research has shown that using Embr Wave provides immediate relief from hot flashes and improves sleep and control over hot flashes for men as they are treated for prostate cancer. The product is sold directly to consumers on embrlabs.com, as well as in leading retail outlets in the US and UK. The Embr Wave is FSA and HSA eligible. Having established successful market traction, Embr is now focused on continuous innovation by deploying hot flash prediction coupled with cooling intervention to prevent hot flashes from occurring.
About Embr Labs, Inc.
Embr Labs is the leading healthtech company addressing the symptoms of chronic health conditions by pioneering the use of temperature as a new pathway to the brain. Embr Wave is now distributed through major US retailers, and internationally in over 25 countries via Embrlabs.com. The company's patented technology has been clinically validated and delivers a brand new category of safe and natural solutions to manage hot flashes, sleep issues, stress, and thermal discomfort. The company was founded by MIT-trained engineers and is backed by investors including Bose Ventures, DigiTx Partners, Safar Partners, Esplanade Ventures, Intel Capital and is backed by Ghost Tree Partners. Embr Labs has won numerous awards for the Embr Wave, including the AARP Innovation in Aging Award, Time Magazine's Best Inventions, the iF Design Award and was named to CB Insights' Digital Health 150.
Media contact: [email protected]
SOURCE Embr Labs
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.